SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 9.75 |
Enterprise Value ($M) | 5.98 |
Book Value ($M) | 23.70 |
Book Value / Share | 7.90 |
Price / Book | 0.41 |
NCAV ($M) | 16.79 |
NCAV / Share | 5.59 |
Price / NCAV | 0.58 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.51 |
Return on Assets (ROA) | -0.28 |
Return on Equity (ROE) | -0.35 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.14 |
Current Ratio | 5.14 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 27.11 |
Assets | 34.02 |
Liabilities | 10.32 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 16.02 |
Operating Income | 5.58 |
Net Income | 3.59 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 8.56 |
Cash from Investing | -22.66 |
Cash from Financing | 15.50 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Alyeska Investment Group, L.P. | 2.50 | -70.50 | |
13G/A | Goldman Sachs Group Inc | 0.00 | -99.93 | |
13G/A | Hirschman Orin | 8.50 | -88.89 | |
13G | Nantahala Capital Management, LLC | 9.99 | ||
13G/A | Lind Global Fund II LP | 3.50 | -87.08 | |
13G | ADAR1 Capital Management, LLC | 9.99 | ||
13G/A | Stonepine Capital Management, LLC | 9.99 | -87.25 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,373 | 6,209 | 22.11 | |
5,059 | 34,427 | 14.69 | |
3,167 | 10,017 | 31.62 | |
994 | 4,322 | 23.00 | |
1,451 | 7,198 | 20.16 | |
(click for more detail) |
Similar Companies | |
---|---|
JAGX – Jaguar Health, Inc. | JSPR – Jasper Therapeutics, Inc. |
KALA – KALA BIO, Inc. | KRRO – Korro Bio, Inc. |
KTTA – Pasithea Therapeutics Corp. |
Financial data and stock pages provided by
Fintel.io